Riskpilot← Back to searchSign inGet full accessJenZens ApS
APSActiveCVR 34585849Assensvej 192Business and other management consultancy activities · NACE 7020Est. 2012— employeeswww.JenZens.dk
Revenue 2025
DKK 4K
+209% vs 2024
EBITDA margin
100.0%
+209% vs 2024
Equity ratio
28.3%
Financial strength
Net profit 2025
DKK 4K
+208% vs 2024
| Revenue | DKK 4K | +209% |
| EBITDA | DKK 4K | +209% |
| Net profit | DKK 4K | +208% |
| Total assets | DKK 474K | +7% |
| Equity | DKK 134K | +3% |
| Employees | — | — |
Legal name
JenZens ApS
CVR number
34585849
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
1. juni 2012
Share capital
DKK 80.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at eje aktier og anparter, samt enhver i forbindelse hermed stående virksomhed.
Address
Assensvej 192
Phone
+4588442824
Email
Info@JenZens.dk
Website
www.JenZens.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -4 | -4 | -6 | -1 | -1 | -1 | 0 | -6 | -17 | -37 | -16 | 1 | 4 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -4 | -4 | -6 | -1 | -1 | -1 | 0 | -6 | -17 | -37 | -16 | 1 | 4 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -4 | -4 | -6 | -1 | -1 | -1 | 0 | -6 | -17 | -37 | -16 | 1 | 4 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.422 | -2.280 | -0 | -0 | 0 | 0 |
| Profit before tax | -4 | -4 | -6 | -1 | -1 | -1 | 0 | 2.416 | -2.296 | -37 | -16 | 1 | 4 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -4 | -4 | -6 | -1 | -1 | -1 | 0 | 2.416 | -2.296 | -37 | -16 | 1 | 4 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 2.667 | 344 | 373 | 355 | 444 | 474 |
| Equity | 76 | 73 | 66 | 65 | 63 | 62 | 62 | 2.478 | 182 | 145 | 129 | 130 | 134 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 | 8 | 14 | 15 | 17 | 18 | 18 | 154 | 162 | 228 | 226 | 314 | 340 |
| Total debt | 4 | 8 | 14 | 15 | 17 | 18 | 18 | 189 | 162 | 228 | 226 | 314 | 340 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20132025
Equity ratio
28.3%
This company
38.2%
Market median
-26% vs market
20132025
Return on equity
2.9%
This company
18.4%
Market median
-84% vs market
20132025
Net profit margin
100.0%
This company
8.1%
Market median
+1135% vs market
20132025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20132025
Debt / equity
2.54×
This company
0.62×
Market median
-310% vs market
20132025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-06-01 – 2013-06-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2020 | |
| Individual | 50.0% | 50.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JenZens ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|